from pg 13 AR
"In June 2021, NEXTSTELLIS was launched into the US market and
is being supported by a highly experienced national women’s
health sales team. By August 2021, the sales team had held 20,000
in-person interactions with prescribers and reached more than
60% of priority prescriber targets."
Suggests there are about 33k priority prescribers in the US. The message is getting out - these docs have better things to do than talk about something of little interest. Assuming Mayne are not counting hang ups and line clicks - lol!
from pg 13 AR "In June 2021, NEXTSTELLIS was launched into the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.00 |
Change
0.080(1.63%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| $4.93 | $5.10 | $4.93 | $3.062M | 610.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67102 | $5.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.05 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |